# A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)

> **NCT04218006** · — · UNKNOWN · sponsor: **TRPHARM** · enrollment: 800 (estimated)

## Conditions studied

- Xanthomatosis, Cerebrotendinous

## Interventions

- **GENETIC:** Mutation Analysis

## Key facts

- **NCT ID:** NCT04218006
- **Lead sponsor:** TRPHARM
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-03
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04218006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04218006, "A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04218006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*